2021 Leon Schiff State-of-the-Art Lecture: Tiny Yet PowerfulMicrobes and Their Potential for Treatment of Liver Diseases
Recorded On: 11/11/2021
Already registered?
Sign in now.
Complex multi-directional interactions occur between the gut microbiota and the liver. A disturbance of this delicate homeostasis can contribute to liver disease. Effects of untargeted microbiota therapies including antibiotics, probiotics and fecal microbiota transplantation, have been assessed in clinical trials. Precision and targeted modifications such as engineered bacteria, postbiotics and phages, can precisely edit the microbiota and modify liver disease progression.